The Latest Cardiac and Vascular News
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has announced a full market release for the 20Fr SEDL version of the PleuraFlow® Active Clearance Technology® System for the treatment of pediatric cardiothoracic surgery patients. The SEDL refers to the “shorter effective drainage length,” which facilitates placement of the […]
Company Gaining Traction with Drug Candidate CVSI-007 to Become the Only FDA Approved Treatment for Smokeless Tobacco Addiction LAS VEGAS, NV–(Marketwired – July 20, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), highlights a recent clinical study using pharmaceutical grade cannabidiol (CBD) which suggests that CBD […]
By Ken Dropkiewski (ken@prime-core.com) In a recent randomized study, researchers determined patients with familial long QT syndrome are susceptible to an increase in symptoms ranging from rapid and irregular heart rate to sudden death just from drinking heavily caffeinated energy drinks. As reported in the International Journal of Cardiology, researchers […]
Cardiac imaging dev VerAvanti raises $5m JULY 18, 2017 BY FINK DENSFORD, MassDevice Previously-stealthy cardiac imaging developer VerAvanti said today it raised $5 million in a recent round of financing to support its Scanning Fiber Endoscope device development. The Redmond, Wash.-based company’s SFE device uses technology licensed from the University of Washington and consists […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company a broad patent (No. 9700655) that covers Ra Medical Systems’ DABRA™ catheter for cardiovascular disease treatment. The patent was granted […]
SAN DIEGO, July 13, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA), as part of its transition to commercial operations, today announced the hiring of a new chief financial officer, a vice president of European sales, and the appointment of a new director to its board. These changes signal the […]
Press release by ETH, By: Franziska Schmid ETH researchers from the Functional Materials Laboratory have developed a silicone heart that beats almost like a human heart. In collaboration with colleagues from the Product Development Group Zurich, they have tested how well it works. The artificial heart imitates a human heart as closely […]
Press Release DUBLIN – July 10, 2017 – Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery. […]
ST. LOUIS PARK, Minn., July 10, 2017 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR), today announced the appointment of Andrew ElBardissi, M.D. to its Board of Directors, effective immediately. Dr. ElBardissi is replacing Avi Kometz, […]
KALAMAZOO, Mich., July 11, 2017 /PRNewswire/ — Innovative Cardiovascular Solutions, LLC (ICS), a privately-held clinical stage company headquartered in Kalamazoo, MI, announced today completion of an oversubscribed Series B round of financing totaling $5M USD. The company is currently developing the EMBLOK™ Embolic Protection System which is designed for use in Transcatheter Aortic Valve Replacement […]
